Help us: Donate
Follow us on:
×

Huntsman Cancer Institute illuminates potential new treatment in acute myeloid leukemia

Huntsman Cancer Institute illuminates potential new treatment in acute myeloid leukemia
Share

(Huntsman Cancer Institute) In a study published in the journal Leukemia, lead author Ami Patel, MD, Huntsman Cancer Institute researcher and assistant professor in the Division of Hematology and Hematologic Malignancies at the University of Utah, showed that factors produced by bone marrow support cells allowed leukemia cells to survive treatment with quizartinib, a type of TKI. When quizartinib was combined with another TKI called dasatinib the alternative survival pathways were shut down, leading to more effective leukemia cell death.

read more...


Article originally posted at

www.eurekalert.org

Click here for the full story


Category
Tags